Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
NCT03272334
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
HER2 BATs with Pembrolizumab
Sponsor
University of Virginia
Collaborators
[object Object]